JPS53109934A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
JPS53109934A
JPS53109934A JP2591278A JP2591278A JPS53109934A JP S53109934 A JPS53109934 A JP S53109934A JP 2591278 A JP2591278 A JP 2591278A JP 2591278 A JP2591278 A JP 2591278A JP S53109934 A JPS53109934 A JP S53109934A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2591278A
Other languages
English (en)
Inventor
Suchiibun Chiyuuri Jiyosefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of JPS53109934A publication Critical patent/JPS53109934A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2591278A 1977-03-07 1978-03-07 Pharmaceutical composition Pending JPS53109934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/774,753 US4083974A (en) 1977-03-07 1977-03-07 Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether

Publications (1)

Publication Number Publication Date
JPS53109934A true JPS53109934A (en) 1978-09-26

Family

ID=25102178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2591278A Pending JPS53109934A (en) 1977-03-07 1978-03-07 Pharmaceutical composition

Country Status (6)

Country Link
US (1) US4083974A (ja)
JP (1) JPS53109934A (ja)
BE (1) BE864645A (ja)
DE (1) DE2806669A1 (ja)
FR (1) FR2382895A1 (ja)
GB (1) GB1547357A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022163686A1 (ja) * 2021-01-26 2022-08-04 シオノギヘルスケア株式会社 ベタメタゾン吉草酸エステル含有軟膏剤組成物

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215116A (en) * 1978-06-30 1980-07-29 Block Drug Company Inc. Propoxylate toxicants
US4213979A (en) * 1978-12-18 1980-07-22 Plough, Inc. Stable sprayable hydrocortisone product
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
PT73772B (en) * 1980-10-06 1983-10-14 Glaxo Group Ltd Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
US4436638A (en) 1981-04-15 1984-03-13 Exxon Research & Engineering Co. Additive composition for release of stuck drill pipe
US4464269A (en) * 1981-07-29 1984-08-07 Exxon Research & Engineering Co. Additive composition for release of stuck drill pipe
SE8404895L (sv) * 1984-10-01 1986-03-17 Torkel Ingemar Fischer Medel for en overkenslighetstest
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4954332A (en) * 1987-10-22 1990-09-04 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US4959205A (en) * 1989-03-23 1990-09-25 Collagen Corporation Composition and method for treatment of dermal inflammation
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
RU2106860C1 (ru) * 1996-01-30 1998-03-20 Акционерное общество открытого типа "Нижегородский химико-фармацевтический завод" Состав и способ получения мази противовоспалительного и противозудного действия
US6086903A (en) * 1996-02-26 2000-07-11 The Proctor & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
CN1263473A (zh) * 1997-05-21 2000-08-16 利兰·斯坦福青年大学托管委员会 增加跨生物膜转运的组合物和方法
FR2787703B1 (fr) * 1998-12-29 2001-01-26 Oreal Nanoemulsion a base d'ethers gras ethoxyles ou d'esters gras ethoxyles, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
PT3146969T (pt) 1999-04-23 2018-10-18 Leo Pharma As Composição farmacêutica para aplicação dérmica para uso no tratamento da psoríase compreendendo vitamina d e um corticosteroide
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US7019194B2 (en) 2001-02-09 2006-03-28 Lennart Hansson SCCE modified transgenic mammals and their use as models of human disease
EP1399467A4 (en) * 2001-05-09 2004-09-15 Newbiotics Inc PRODRUGS ACTIVATED BY PEPTIDDEFORMYLASE
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
AU2003225047A1 (en) * 2002-04-18 2003-11-03 Celmed Oncology (Usa), Inc. Peptide deformylase activated prodrugs
AU2003228819A1 (en) * 2002-05-03 2003-11-17 Combinatorx, Incorporated Combinations for the treatment of inflammatory skin disorders
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
AU2003290779A1 (en) * 2002-11-14 2004-06-03 Celmed Oncology (Usa), Inc. Peptide deformylase activated prodrugs
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
AU2005201455A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
JP2005310310A (ja) * 2004-04-23 2005-11-04 Sanyo Electric Co Ltd トラッキングバランス調整装置
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
JP5732471B2 (ja) * 2009-12-22 2015-06-10 レオ ファーマ アクティーゼルスカブ 溶媒混合物およびビタミンｄ誘導体から成る医薬品組成物または類似体
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
JP6997624B2 (ja) 2015-06-18 2022-01-17 ボシュ ヘルス ユーエス，エルエルシー． 乾癬を治療するためのコルチコステロイドおよびレチノイドを含む局所用組成物
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL267783A (ja) * 1900-01-01
FR682M (ja) * 1960-09-26 1961-07-17
FR1044M (fr) * 1960-12-20 1962-01-08 Bernard Mirande Utilisation de substances tensio-actives dans des préparations pharmaceutiques destinées aux traitements des ulcérations cutanées non infectieuses.
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
US3924004A (en) * 1971-11-24 1975-12-02 Syntex Corp Fatty alcohol-propylene carbonate-glycol solvent cream vehicle
US3966924A (en) * 1974-11-13 1976-06-29 Allergan Pharmaceuticals Composition and method for treating psoriasis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022163686A1 (ja) * 2021-01-26 2022-08-04 シオノギヘルスケア株式会社 ベタメタゾン吉草酸エステル含有軟膏剤組成物
JPWO2022163686A1 (ja) * 2021-01-26 2022-08-04

Also Published As

Publication number Publication date
FR2382895B1 (ja) 1980-08-29
BE864645A (fr) 1978-09-07
FR2382895A1 (fr) 1978-10-06
US4083974A (en) 1978-04-11
GB1547357A (en) 1979-06-13
DE2806669A1 (de) 1978-09-14

Similar Documents

Publication Publication Date Title
JPS53113007A (en) Pharmaceutical composition
JPS53109934A (en) Pharmaceutical composition
SG34985G (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
JPS5484022A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
PH15193A (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
GB2021409B (en) Pharmaceutical composition
GB2008403B (en) Pharmaceutical compositions
MW478A1 (en) Pharmaceutical compositions
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
JPS5394038A (en) Pharmaceutical composition
JPS5486607A (en) Solid pharmaceutical composition
NZ186334A (en) Oxadiazolopyrimidines:pharmaceutical compositions
IL54220A (en) Pharmaceutical compositions comprising trans-broparestrol
JPS53101520A (en) Pharmaceutical composition
GB2008408B (en) Pharmaceutical compositions
JPS545045A (en) Pharmaceutical composition
ZA7812B (en) Pharmaceutical compositions
ZA782736B (en) Pharmaceutical compositions
GB1556851A (en) Pharmaceutical compositions
JPS542338A (en) Pharmaceutical composition
JPS5480427A (en) Pharmaceutical composition having antiiviral property